Advances in Infectious Diseases and Clinical Microbiology during the COVID-19 Pandemic

The COVID-19 pandemic caused a change in the pattern of various infectious diseases. Evidence suggests that the same nonpharmaceutical interventions employed to prevent the transmission of SARS-CoV-2 likely led to the reduced incidence of influenza in various regions across the globe. However, the C...

Full description

Saved in:
Bibliographic Details
Other Authors: Khan, Yusra Habib (Editor), Mallhi, Tauqeer Hussain (Editor), Khan, Tahir Mehmood (Editor), Salman, Muhammad (Editor)
Format: Electronic Book Chapter
Language:English
Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_128855
005 20231130
003 oapen
006 m o d
007 cr|mn|---annan
008 20231130s2023 xx |||||o ||| 0|eng d
020 |a books978-3-0365-9469-9 
020 |a 9783036594682 
020 |a 9783036594699 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-0365-9469-9  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a H  |2 bicssc 
072 7 |a JFFP  |2 bicssc 
100 1 |a Khan, Yusra Habib  |4 edt 
700 1 |a Mallhi, Tauqeer Hussain  |4 edt 
700 1 |a Khan, Tahir Mehmood  |4 edt 
700 1 |a Salman, Muhammad  |4 edt 
700 1 |a Khan, Yusra Habib  |4 oth 
700 1 |a Mallhi, Tauqeer Hussain  |4 oth 
700 1 |a Khan, Tahir Mehmood  |4 oth 
700 1 |a Salman, Muhammad  |4 oth 
245 1 0 |a Advances in Infectious Diseases and Clinical Microbiology during the COVID-19 Pandemic 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2023 
300 |a 1 electronic resource (250 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a The COVID-19 pandemic caused a change in the pattern of various infectious diseases. Evidence suggests that the same nonpharmaceutical interventions employed to prevent the transmission of SARS-CoV-2 likely led to the reduced incidence of influenza in various regions across the globe. However, the COVID-19 pandemic caused disruptions in the reporting of other infectious diseases such as sexually transmitted diseases and other coronavirus infections. Decreased reporting of notifiable infectious diseases and conditions during the pandemic remained a major concern for health authorities. Ascertaining the impact of the COVID-19 pandemic on the transmission patterns of other infectious diseases holds significant implications for public health, but this topic has not yet been studied to a greater extent. On the other hand, the scope and relevance of clinical microbiology are appreciated more than ever. Viral structure, transmission, diagnosis, and optimal sterilization and disinfection process were the key elements that clinical microbiologists shared for the betterment of the community throughout the pandemic. This issue underscores various aspects of the advancements in infectious diseases and clinical microbiology during the ongoing COVID-19 pandemic. This Special Issue highlights the need for integrated efforts to control any future outbreak along with parallel management of other infectious diseases. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Humanities  |2 bicssc 
650 7 |a Social interaction  |2 bicssc 
653 |a n/a 
653 |a COVID-19 
653 |a antibiotic therapy 
653 |a mortality 
653 |a female gender 
653 |a neoplasm history 
653 |a heart failure 
653 |a diabetes mellitus 
653 |a aspirin 
653 |a elderly population 
653 |a low molecular weight heparin 
653 |a pulmonary thromboembolism 
653 |a hospital stay 
653 |a parental knowledge 
653 |a HPV infection 
653 |a HPV vaccine 
653 |a children 
653 |a adolescents 
653 |a NSAID 
653 |a duration 
653 |a side effects 
653 |a safety 
653 |a vaccine hesitancy 
653 |a comorbidities 
653 |a hypertension 
653 |a hyperlipidemia 
653 |a pharmacovigilance 
653 |a SARS-CoV-2 
653 |a sequencing 
653 |a Nanopore 
653 |a MinION 
653 |a Ion Torrent 
653 |a mediterranean diet 
653 |a inflammatory factors 
653 |a stress oxidative 
653 |a appetite 
653 |a antiviral 
653 |a clinical outcome 
653 |a coronavirus 
653 |a disease severity 
653 |a Saudi Arabia 
653 |a vaccine 
653 |a knowledge 
653 |a attitude 
653 |a perception 
653 |a survey 
653 |a questionnaire 
653 |a breakthrough infections 
653 |a neutralizing antibodies (NAbs) 
653 |a Omicron 
653 |a vaccines 
653 |a variants 
653 |a latent tuberculosis infection 
653 |a hemodialysis 
653 |a QuantiFERON-TB Gold Plus assay 
653 |a Lebanon 
653 |a dexamethasone 
653 |a tocilizumab 
653 |a epidural abscess 
653 |a bacteremia 
653 |a inflammatory markers 
653 |a therapeutic plasma exchange 
653 |a plasmapheresis 
653 |a monkeypox outbreak 
653 |a public health 
653 |a emergency 
653 |a Peru 
653 |a coinfections 
653 |a antimicrobials 
653 |a Colombia 
653 |a epidemiology 
653 |a superinfections 
653 |a telemedicine 
653 |a primary practice 
653 |a ophthalmological diseases 
653 |a HIV infection 
653 |a CMV retinitis 
653 |a tuberculosis verrucosa cutis (TBVC) 
653 |a multifocal 
653 |a infectious diseases 
653 |a tuberculosis 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/8325  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/128855  |7 0  |z DOAB: description of the publication